Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

228.89
Delayed Data
As of May 24
 +3.38 / +1.50%
Today’s Change
195.50
Today|||52-Week Range
340.34
-26.76%
Year-to-Date
Billionaires are Dumping These 3 Stocks
8:41am / MotleyFool.com - Paid Partner Content
Everything You Need to Know About Pfizer's Growth Strategy, Summed Up by Its CEO
May 13 / MotleyFool.com - Paid Partner Content
Billionaires Are Bailing on Pfizer, Inc -- Should You?
May 24 / MotleyFool.com - Paid Partner Content
Down 27%, Is It Time to Buy Allergan Stock? 3 Things You Need to Know
May 13 / MotleyFool.com - Paid Partner Content
Today's Trades
May 24 / TheStreet.com - Paid Partner Content
Stock Market News for May 13, 2016
May 13 / Zacks.com - Paid Partner Content
Is Biotech About to Go from Goat to Hero?
May 24 / TheStreet.com - Paid Partner Content
Stocks: 4 things to know before the open
May 13 / CNNMoney.com
What the Sharp Dropoff in Buybacks Says About the Market
May 24 / TheStreet.com - Paid Partner Content
3 Risky Biotechs With FDA Decisions On Deck -- Are They Buys?
May 12 / MotleyFool.com - Paid Partner Content
CF Industries Ends $8B OCI Deal Due to Tax Inversion Rules
May 24 / Zacks.com - Paid Partner Content
3 Cheap Growth Stocks You Can Buy Right Now
May 12 / MotleyFool.com - Paid Partner Content
Billionaires Lightened Their Load on These 3 Widely-Held Stocks in Q1
May 24 / MotleyFool.com - Paid Partner Content
Blocked US deals a sign that mergers have become more aggressive
May 11 / FT.com - Paid Partner Content
Allergan to do Smaller Deals and Boost Credit Rating
May 23 / TheStreet.com - Paid Partner Content
Instant Analysis: Allergan Launches $10B Share Buyback Program
May 11 / MotleyFool.com - Paid Partner Content
CF Industries Pulls $8B Takeover of OCI Assets
May 23 / TheStreet.com - Paid Partner Content
Norwegian Cruise shares fall on downbeat outlook
May 10 / FT.com - Paid Partner Content
'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market
May 22 / GuruFocus News - Paid Partner Content
Allergan: kicking the habit
May 10 / FT.com - Paid Partner Content
John Paulson's Top 4 New Buys Not Health Care or Gold
May 18 / GuruFocus News - Paid Partner Content
Allergan rolls out $10bn buyback revival plan
May 10 / FT.com - Paid Partner Content
John Paulson Trims Time Warner Cable, Starwood Hotels
May 18 / GuruFocus News - Paid Partner Content
Stocks: 3 things to know before the open
May 10 / CNNMoney.com
Dell bonds draw $85bn in investor orders
May 17 / FT.com - Paid Partner Content
Freeport declines after mine stake deal
May 09 / FT.com - Paid Partner Content
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
May 17 / Zacks.com - Paid Partner Content
Pfizer to trial triple-combination cancer treatment
May 09 / FT.com - Paid Partner Content
Pfizer to Buy Anacor, Add Eczema Treatment to Portfolio
May 17 / Zacks.com - Paid Partner Content
Allergan chief persists with his prescription for growth
May 08 / FT.com - Paid Partner Content
Why Synergy Pharmaceuticals Is Spiking 13% Today
May 16 / MotleyFool.com - Paid Partner Content
Pfizer weighs split to cut tax bill
May 04 / FT.com - Paid Partner Content
Last Week's Best Healthcare ETF
May 14 / MotleyFool.com - Paid Partner Content
Daniel Loeb warns of hedge fund 'killing field'
Apr 27 / FT.com - Paid Partner Content
5 Stocks We're Never Selling
May 14 / MotleyFool.com - Paid Partner Content